# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-325034
Filing Date
2026-07-30
Accepted
2026-07-30 08:34:55
Documents
66
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | iron-20260630.htm iXBRL | 10-Q | 2719520
2 | EX-10.1 | iron-ex10_1.htm | EX-10.1 | 1418272
3 | EX-31.1 | iron-ex31_1.htm | EX-31.1 | 16953
4 | EX-31.2 | iron-ex31_2.htm | EX-31.2 | 16614
5 | EX-32.1 | iron-ex32_1.htm | EX-32.1 | 10379
| Complete submission text file | 0001193125-26-325034.txt |  | 10136180

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | iron-20260630.xsd | EX-101.SCH | 823219
70 | EXTRACTED XBRL INSTANCE DOCUMENT | iron-20260630_htm.xml | XML | 1455257

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 261220372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)